I-Mab Biopharma
Shanghai
About I-Mab Biopharma
I-MAB is a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel or highly differentiated biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders. .
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Total funding: $880.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Aug 2025)
- Ticker: nasdaq:IMAB
- Website: i-mabbiopharma.com
- Phone: +862160578000
Industries & Categories
Biotechnology, Pharmaceutical, Product Research
Social Profiles
Canonical: https://fsome.com/organization/i-mab-biopharma-63820 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.